{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:58:07Z","timestamp":1793465887281,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011286","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T00:00:00Z","timestamp":1476057600000}}],"reference-count":140,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011286.pub2","type":"journal-article","created":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T16:03:10Z","timestamp":1476374590000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["S-adenosyl methionine (SAMe) for depression in adults"],"prefix":"10.1002","volume":"2016","author":[{"given":"Ilaria","family":"Galizia","sequence":"first","affiliation":[{"name":"King's College London, Institute of Psychiatry; Centre for Affective Disorders; De Crespigny Park London UK SE5 8AF"},{"name":"Department of Basic Medical Science, Neuroscience and Sense Organs, Aldo Moro University; Bari Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Oldani","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Mental Health; Via F. Sforza 35 Milan Italy 20122"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Macritchie","sequence":"additional","affiliation":[{"name":"King's College; c\/o Ms Caroline Loveland, Centre for Affective Disorders, Institute of Psychiatry; Denmark Hill London UK SE5 8AF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Amari","sequence":"additional","affiliation":[{"name":"University of British Columbia; eHealth Strategy Office; 855 West 10th Ave Vancouver BC Canada V5Z 1L7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Dougall","sequence":"additional","affiliation":[{"name":"East London NHS Foundation Trust; Newham Centre for Mental Health; Glen Road Cherry Tree Way London UK E13 8SP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa N","family":"Jones","sequence":"additional","affiliation":[{"name":"Central and North West London NHS Foundation Trust; The Claybrook Centre; 37 Claybrook Road Hammersmith London UK W6 8LN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond W","family":"Lam","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Psychiatry; 2255 Wesbrook Mall Vancouver BC Canada V6T 2A1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido Jacopo","family":"Massei","sequence":"additional","affiliation":[{"name":"University of Pisa; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology; Via Roma 67 Pisa Italy 56126"},{"name":"Versilia Hospital; UOC Psichiatria; Lido di Camaiore Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi N","family":"Yatham","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Psychiatry; 2255 Wesbrook Mall Vancouver BC Canada V6T 2A1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H","family":"Young","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, King's College London; Centre for Affective Disorders; PO72, De Crespigny Park Denmark Hill London UK SE5 8AF"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,10,10]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD011286.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1176\/ajp.145.9.1110","article-title":"S-adenosylmethionine treatment of depression: a controlled clinical trial","volume":"145","author":"Bell","year":"1988","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD011286.pub2-BIB0002|cit2","first-page":"313","article-title":"Rapid antidepressant response with SAMe. A double-study","volume":"25","author":"Potkin","year":"1988","journal-title":"Alabama Journal of Medical Sciences"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0003|cit3","unstructured":"Bell KM Carreon D Plon L Bunney We Jr Potkin SG Oral S-adenosylmethionine in the treatment of depression: a double-blind comparison with desipramine. Study report BioResearch File 1990 53 4"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011286.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0404.1994.tb05404.x","article-title":"S-adenosylmethionine blood levels in major depression: changes with drug treatment","volume":"154","author":"Bell","year":"1994","journal-title":"Acta Neurologica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD011286.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ajcn\/76.5.1172S","article-title":"Efficacy and tolerability of oral and intramuscular s-adenosyl-l-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicentrum studies","volume":"76","author":"Delle Chiaie","year":"2002","journal-title":"American Journal of Clinical Nutrition"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011286.pub2-BIB0006|cit6","first-page":"S230","article-title":"Mc3: multicentre, controlled efficacy and safety trial of oral S-adenosyl-methionine (SAMe) vs oral imipramine in the treatment of depression","volume":"3","author":"Delle Chiaie","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011286.pub2-BIB0007|cit7","first-page":"230","article-title":"Multicentre, controlled efficacy and safety trial of S-adenosyl-methionine (SAMe) vs oral imipramine in the treatment of depression","volume":"3","author":"Delle Chiaie","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0008|cit8","unstructured":"Delle Chiaie R Pancheri P Scapicchio P S-adenosyl-methionine (SAMe) in major depression: two multicenter trials versus imipramine 155th Annual Meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia, PA 2002"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0009|cit9","unstructured":"Delle Chiaie R Pancheri R Scapicchio P S-adenosyl-methionine (SAMe) in major depression: two multicenter trials versus imipramine 154th Annual Meeting of the American Psychiatric Association; 2001 May 5-10, New Orleans 2000 NR499"},{"issue":"5","key":"10.1002\/14651858.CD011286.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ajcn\/76.5.1172S","article-title":"Efficacy and tolerability of oral and intramuscular s-adenosyl-l-methionine 1,4-butanedisulfunate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies","volume":"76","author":"Delle Chiaie","year":"2002","journal-title":"American Journal of Clinical Nutrition"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011286.pub2-BIB0011|cit11","first-page":"S230","article-title":"Mc4: multicentre, controlled efficacy and safety trial of intramuscular S-adenosylmethionine (SAMe) versus oral imipramine in the treatment of depression","volume":"3","author":"Delle Chiaie","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0012|cit12","unstructured":"Delle Chiaie R Pancheri P Scapicchio P S-adenosyl-methionine (SAMe) in major depression: two multicenter trials versus imipramine 154th Annual Meeting of the American Psychiatric Association; 2001 May 5-10, New Orleans 2001 NR499"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0013|cit13","unstructured":"Delle Chiaie R Pancheri P Scapicchio P S-adenosyl-methionine (SAMe) in major depression: two multicenter trials versus imipramine 155th Annual Meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia, PA 2002"},{"issue":"4","key":"10.1002\/14651858.CD011286.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1017\/S1461145702003085","article-title":"A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder","volume":"5","author":"Pancheri","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD011286.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0011-393X(05)80424-2","article-title":"Oral S-adenosyl-l-methionine in depression","volume":"52","author":"Vanna","year":"1992","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"5","key":"10.1002\/14651858.CD011286.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1176\/ajp.147.5.591","article-title":"Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial","volume":"147","author":"Kagan","year":"1990","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0017|cit17","unstructured":"Fava M A double-blind, placebo-controlled study of the alternative therapy S-adenosyl-l-methionine (SAMe) versus escitalopram in major depressive disorder clinicaltrials.gov\/show\/NCT00101452"},{"issue":"11","key":"10.1002\/14651858.CD011286.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"e1328","DOI":"10.4088\/JCP.14lr09266","article-title":"Failed studies should not be used to malign good treatments [NCT00101452]","volume":"75","author":"Gerbarg","year":"2014","journal-title":"Journal of Clinical Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD011286.pub2-BIB0020|cit19","doi-asserted-by":"crossref","first-page":"e1328","DOI":"10.4088\/JCP.14lr09266","article-title":"Dr. Mischoulon and colleagues reply [NCT00101452]. Comment on failed studies should not be used to malign good treatments","volume":"75","author":"Mischoulon","year":"2014","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD011286.pub2-BIB0019|cit20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4088\/JCP.13m08591","article-title":"A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-l-methionine (SAMe) versus escitalopram in major depressive disorder","volume":"75","author":"Mischoulon","year":"2014","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jad.2014.03.041","article-title":"S-adenosylmethionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response","volume":"164","author":"Sarris","year":"2014","journal-title":"Journal of Affective Disorders"},{"issue":"4-5","key":"10.1002\/14651858.CD011286.pub2-BIB0022|cit22","first-page":"141","article-title":"Is S-adenosyl methionine (SAMe) for depression only effective in males? A re-analysis of data from a randomized controlled trial","volume":"48","author":"Sarris","year":"2015","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1002\/14651858.CD011286.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4088\/JCP.11m07139","article-title":"Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder [NCT00093847]","volume":"73","author":"Mischoulon","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0025|cit24","unstructured":"Papakostas GI S-Adenosyl methionine (SAMe) augmentation of selective serotonin reuptake inhibitors (SSRIs) for treatment-resistant depression (TRD) clinicaltrials.gov\/show\/NCT00093847"},{"issue":"8","key":"10.1002\/14651858.CD011286.pub2-BIB0024|cit25","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/appi.ajp.2009.09081198","article-title":"S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial","volume":"167","author":"Papakostas","year":"2010","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD011286.pub2-BIB0026|cit26","first-page":"567","article-title":"Neuropsychiatric disorders and transmethylations: therapeutic effects of S adenosyl L methionine","volume":"75","author":"Agnoli","year":"1975","journal-title":"Clinica Terapeutica"},{"issue":"1","key":"10.1002\/14651858.CD011286.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0022-3956(76)90008-X","article-title":"Effect of S-adenosyl-l-methionine (SAMe) upon depressive symptoms","volume":"13","author":"Agnoli","year":"1976","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/978-3-642-88516-7_18","article-title":"Results and possible developments of the clinical use of S-adenosyl-L-methionine (SAMe) in psychiatry","volume":"18","author":"Agnoli","year":"1978","journal-title":"Monographien aus dem Gesamtgebiete der Psychiatrie"},{"issue":"4","key":"10.1002\/14651858.CD011286.pub2-BIB0029|cit29","first-page":"275","article-title":"Double blind study on the antidepressant activity of sulfoadenosyl-L-methionine (SAMe): clinical and biological factors","volume":"11","author":"Alvarez","year":"1984","journal-title":"Revista del Departamento de Psiquiatr\u00eda de la Facultad de Medicina de Barcelona"},{"issue":"1","key":"10.1002\/14651858.CD011286.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.aimed.2015.04.003","article-title":"S-adenosylmethionine (SAMe) and magnesium orotate as adjunctives to SSRIs in sub-optimal treatment response of depression in adults: a pilot study","volume":"2","author":"Bambling","year":"2015","journal-title":"Advances in Integrative Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011286.pub2-BIB0031|cit31","first-page":"235","article-title":"The clinical effects of S-adenosyl-L-methionine (SAMe) in cases of depression","volume":"19","author":"Barberi","year":"1978","journal-title":"Minerva Psichiatrica"},{"issue":"3","key":"10.1002\/14651858.CD011286.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0165-1781(92)90029-3","article-title":"Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine","volume":"44","author":"Berlanga","year":"1992","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1002\/14651858.CD011286.pub2-BIB0033|cit33","first-page":"35","article-title":"Comparative study of sulfoadenosyl-l-methionine and amoxapine in depression","volume":"6","author":"Blasi Ras","year":"1985","journal-title":"Psiquis, Revista de Psiquiatria, Psicologia y Psicosomatica"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4612-5012-8_27","article-title":"A biochemical study of depressed patients receiving S-adenosyl-L-methionine (SAM)","volume":"12","author":"Bottiglieri","year":"1986","journal-title":"Biological Methylation and Drug Design. Experimental Biology and Medicine"},{"issue":"12","key":"10.1002\/14651858.CD011286.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/jnnp.53.12.1096","article-title":"Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine","volume":"53","author":"Bottiglieri","year":"1990","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD011286.pub2-BIB0036|cit36","first-page":"147","article-title":"The antidepressant action of SAMe compared with that of chloripramine and an interpretation of its mechanism","volume":"20","author":"Calandra","year":"1979","journal-title":"Minerva Psichiatrica"},{"issue":"4","key":"10.1002\/14651858.CD011286.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00002826-198608000-00005","article-title":"Affective illness and S adenosylmethionine: a preliminary report","volume":"9","author":"Carney","year":"1986","journal-title":"Clinical Neuropharmacology"},{"issue":"6","key":"10.1002\/14651858.CD011286.pub2-BIB0038|cit38","first-page":"865","article-title":"S-adenosylmethionine as an antidepressant: a double-blind trial versus placebo","volume":"41","author":"Leo","year":"1987","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0039|cit39","unstructured":"Delle Chiaie R Boissard G Meta-analysis of two European multicenter controlled trials with ademetionine (SAMe) in major depression 6th World Congress of Biological Psychiatry; 1997 22-27 Jun; Nice, France 1997"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0040|cit40","first-page":"1","article-title":"Combined analysis of two controlled, multicentric, double-blind studies to assess efficacy and safety of sulfo-adenosyl-methionine (SAMe) vs. placebo (MC1) and SAMe vs. clomipramine (MC2) in the treatment of major depression","volume":"5","author":"Delle Chiaie","year":"1999","journal-title":"Giornale Italiano di Psicopatologia"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0041|cit41","first-page":"344","article-title":"Has SAMe (Ado Met) and antidepressant effect: a preliminary trial versus chlorimipramine","volume":"102","author":"Vecchio","year":"1978","journal-title":"Rivista Sperimentale di Freniatria"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/IJGM.S79518","article-title":"Preliminary results of a randomized controlled trial carried out with a fixed combination of S-adenosyl-L-methionine and betaine versus amitriptyline in patients with mild depression","volume":"8","author":"Pierro","year":"2015","journal-title":"International Journal of General Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011286.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0447.1992.tb03223.x","article-title":"The thyrotropin response to thyrotropin-releasing hormone as a predictor of response to treatment in depressed outpatients","volume":"86","author":"Fava","year":"1992","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD011286.pub2-BIB0044|cit44","first-page":"238","article-title":"Parenteral S-adenosylmethionine (SAMe) in depression; literature review and preliminary data","volume":"25","author":"Janicak","year":"1989","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD011286.pub2-BIB0045|cit45","first-page":"306","article-title":"S-adenosylmethionine in depression. A literature review and preliminary report","volume":"25","author":"Janicak","year":"1988","journal-title":"Alabama Journal of Medical Sciences"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0046|cit46","first-page":"175","article-title":"Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant","volume":"32","author":"Kufferle","year":"1982","journal-title":"Advances in Biochemical Psychopharmacology"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0047|cit47","first-page":"397","article-title":"SAMe in depressive syndromes","volume":"2","author":"Lanaia","year":"1977","journal-title":"Igiene Mentale"},{"issue":"12","key":"10.1002\/14651858.CD011286.pub2-BIB0048|cit48","first-page":"707","article-title":"Depressive syndromes, skin disease and transmethylations. Therapeutic effects of S adenosyl L methionine","volume":"135","author":"Mantero","year":"1976","journal-title":"Gazzetta Medica Italiana"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0049|cit49","first-page":"151","article-title":"SAMe versus placebo: a double blind comparison in major depressive disorders","volume":"32","author":"Muscettola","year":"1982","journal-title":"Advances in Biochemical Psychopharmacology"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0050|cit50","first-page":"305","article-title":"Effects of the association of maprotiline + SAMe in depressive syndromes","volume":"3","author":"Rabassini","year":"1979","journal-title":"Psichiatria Generale e Dell'eta' Evolutiva"},{"issue":"1","key":"10.1002\/14651858.CD011286.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000288642","article-title":"Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women","volume":"59","author":"Salmaggi","year":"1993","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"2 pt 2","key":"10.1002\/14651858.CD011286.pub2-BIB0052|cit52","first-page":"58","article-title":"Oral S-adenosylmethionine (SAMe) in the treatment of menopausal depressive disorder (MDD): a double-blind placebo controlled trial","volume":"21","author":"Salmaggi","year":"1991","journal-title":"European Journal of Clinical Investigation"},{"issue":"1","key":"10.1002\/14651858.CD011286.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.aimed.2015.02.001","article-title":"An adjunctive antidepressant nutraceutical combination in treating major depression: study protocol, and clinical considerations","volume":"2","author":"Sarris","year":"2015","journal-title":"Advances in Integrative Medicine"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0054|cit54","first-page":"359","article-title":"A double-blind clinical comparison of SAMe vs clomipramine in depressive disorders","volume":"102","author":"Scarzella","year":"1978","journal-title":"Rivista Sperimentale di Freniatria"},{"issue":"3","key":"10.1002\/14651858.CD011286.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0924-977X(93)90107-W","article-title":"Dothiepin vs S-adenosylmethionine (SAMe) for the treatment of major depression in weaned alcoholics: a pilot study","volume":"3","author":"Schifano","year":"1993","journal-title":"European Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD011286.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00004850-198704000-00001","article-title":"The influence of S-adenosylmethionine (SAM) on prolactin in depressed patients","volume":"2","author":"Thomas","year":"1987","journal-title":"International Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD011286.pub2-BIB0057|cit57","first-page":"265","article-title":"Assessment of a new drug for depression: S-adenosyl-L-methionine","volume":"2","author":"Quiros","year":"1982","journal-title":"Psicopatologia"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0059|cit58","unstructured":"Sarris J Nutraceuticals as monotherapy treatments in major depressive disorder: a double-blind, randomised, placebo-controlled trial, 2013 www.anzctr.org.au\/ACTRN12613001299796.aspx"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0058|cit59","unstructured":"Sarris J Murphy J The efficacy of S-adenosyl methionine (SAMe) and a combination nutraceutical as monotherapy treatments in major depressive disorder: a double-blind, randomised, placebo-controlled trial www.anzctr.org.au\/ACTRN12613001299796.aspx"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0060|cit60","unstructured":"Sarris J The efficacy of S-adenosylmethionine (SAMe) and a combination nutraceutical as adjunctive treatments in depression: a double-blind, randomized, placebo-controlled trial, 2013 www.anzctr.org.au\/ACTRN12613001300763.aspx"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0061|cit61","unstructured":"MSI Methylation Sciences Inc A double-blind, placebo-controlled, randomized add-on study of MSI-195 (Methylation Sciences Inc. S-adenosyl-L-methionine, SAMe) for patients with major depressive disorder (MDD) who have had an inadequate response to current antidepressant therapy, 2013 clinicaltrials.gov\/show\/NCT01912196"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0062|cit62","volume-title":"Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]","author":"Alderson","year":"2004"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-08-024929-2.50013-1","article-title":"Changes in rat brain noradrenaline and serotonin after administration of S-adenosylmethionine","volume-title":"Biochemical and Pharmacological Roles of Adenosylmethionine and the Central Nervous System","author":"Algeri","year":"1979"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.312.7030.572","article-title":"Statistics notes: presentation of numerical data","volume":"312","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"7066","key":"10.1002\/14651858.CD011286.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0066|cit66","first-page":"103","article-title":"Shortening of latency period in depressed patients treated with SAMe and other antidepressant drugs","volume":"S1","author":"Alvarez","year":"1987","journal-title":"Cell Biology Reviews"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0067|cit67","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0068|cit68","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0069|cit69","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0070|cit70","unstructured":"American Psychiatric Association Practice guideline for the treatment of patients with major depressive disorder, 3rd edition 2010"},{"issue":"3","key":"10.1002\/14651858.CD011286.pub2-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007954","article-title":"Antidepressants versus placebo for depression in primary care","author":"Arroll","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0072|cit72","unstructured":"Bell KM Potkin SG Carreon L Plot L Bunney W Oral S-adenosylmethionine in the treatment of depression: a double-blind, randomized comparison with desipramine American Journal Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0073|cit73","first-page":"111","article-title":"A controlled clinical trial of S-adenosylmethionine treatment of depression","volume":"S1","author":"Bell","year":"1987","journal-title":"Annual Review of Cell and Developmental Biology"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/070674370705200108","article-title":"Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods","volume":"52","author":"Berlim","year":"2007","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0076|cit76","volume-title":"British National Formulary","author":"Royal Pharmaceutical Society of Great Britain","year":"September 2016"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1151S","DOI":"10.1093\/ajcn\/76.5.1151S","article-title":"S-adenosyl-L-methionine (SAMe): from the bench to the bedside - molecular basis of a pleiotrophic molecule","volume":"78","author":"Bottiglieri","year":"2002","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0404.1994.tb05403.x","article-title":"S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies","volume":"154","author":"Bressa","year":"1994","journal-title":"Acta Neurologica Scandinavica. Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD011286.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/11537360-000000000-00000","article-title":"Impact of treatment success on health service use and cost in depression: longitudinal database analysis","volume":"29","author":"Byford","year":"2011","journal-title":"Pharmacoeconomics"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1021\/ja01131a519","article-title":"The nature of the active methyl donor formed enzymatically from L-methionine and adenosine triphosphate","volume":"74(11)","author":"Cantoni","year":"1952","journal-title":"Journal of the American Chemical Society"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1192\/bjp.154.1.48","article-title":"The switch mechanism and the bipolar\/unipolar dichotomy","volume":"154","author":"Carney","year":"1989","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011286.pub2-BIB0082|cit82","first-page":"17","article-title":"St. John's wort and S-adenosyl methionine as \"natural\" alternatives to conventional antidepressants in the era of the suicidality boxed warning: what is the evidence for clinically relevant benefit?","volume":"16","author":"Carpenter","year":"2011","journal-title":"Alternative Medicine Review"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ajhp\/57.2.119","article-title":"SAMe: S-Adenosylmethionine","volume":"57(2)","author":"Chavez","year":"2000","journal-title":"American Journal of Health-System Pharmacy"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0084|cit84","volume-title":"NHS Economic Evaluation Database Handbook","author":"Craig","year":"2007"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1176\/appi.ajp.2010.10040627","article-title":"S-Adenosyl Methionine (SAMe) augmentation in major depressive disorder","volume":"167","author":"Craig Nelson","year":"2010","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011286.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0364-7722(78)90023-1","article-title":"Effect of S-adenosyl-L-methionine on serotonin metabolism in rat brain","volume":"2","author":"Curcio","year":"1978","journal-title":"Progress in Neuro-Psychopharmacology"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"e04","DOI":"10.4088\/JCP.9058se1c.04gry","article-title":"Major depressive disorder treatment guidelines in America and Europe","volume":"71 Suppl E1","author":"Davidson","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1172S","DOI":"10.1093\/ajcn\/76.5.1172S","article-title":"Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies","volume":"76(5)\u00a0","author":"Delle Chiaie","year":"2002","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in Clinical Trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0090|cit90","unstructured":"Di Padova C Giudici A Boissard G Ademetionine and depression IV Workshop on methionine metabolism: molecular mechanisms and clinical implications; 2000 Feb 20-24; Granada, Spain 2000 295 9"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/1531-8257(200011)15:6<1225::AID-MDS1025>3.0.CO;2-A","article-title":"S-Adenosyl methionine improves depression in patients with Parkinson's disease in an open-label clinical trial","volume":"15 (6)","author":"Rocco","year":"2000","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bmj.313.7052.275","article-title":"Guidelines for authors and peer reviewers of economic submissions to the BMJ","volume":"313","author":"Drummond","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0094|cit94","first-page":"8","article-title":"Anxiety syndromes and their relationship to depressive illness","volume":"44(8, Pt2)","author":"Fawcett","year":"1983","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0095|cit95","first-page":"1015","article-title":"Therapy of schizophrenic and depressive disorders with S-adenosylmethionine","volume":"2","author":"Fazio","year":"1974","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD011286.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1176\/appi.ajp.2010.10091252","article-title":"Discrepancy in response and remission rates for SAMe-treated patients in a double-blind, randomized clinical trial [comment]","volume":"167","author":"Fleisch","year":"2010","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD011286.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/da.21939","article-title":"The importance of anxiety in both major depression and bipolar disorder","volume":"29","author":"Goldberg","year":"2012","journal-title":"Depression and Anxiety"},{"issue":"12","key":"10.1002\/14651858.CD011286.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4088\/JCP.v64n1211","article-title":"The economic burden of depression in the United States: how did it change between 1990 and 2000?","volume":"64","author":"Greenberg","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD011286.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1592\/phco.24.16.1501.50943","article-title":"Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans","volume":"24","author":"G\u00f6ren","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0103|cit103","unstructured":"Hardy M Coulter I Morton SC Favreau J Venuturupalli S Chiappelli F S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease Evidence Report\/Technology Assessment Number 64. Rockville, MD: Agency for Healthcare Research and Quality October 2002"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.psychres.2005.07.012","article-title":"Treatment of depression with atypical features: a meta-analytic approach","volume":"141","author":"Henkel","year":"2006","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0105|cit105","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011286.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psc.2011.11.005","article-title":"The costs of depression","volume":"35","author":"Kessler","year":"2012","journal-title":"Psychiatric Clinics of North America"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0108|cit108","volume-title":"Paying the Price. The Cost of Mental Health Care in England to 2026","author":"McCrone","year":"2008"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S0021-9258(20)79170-2","article-title":"An escape from Italy, the discovery of S-adenosylmethionine, and the biosynthesis of creatine by Giulio L. Cantoni","volume":"280","author":"Kresge","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1176\/ajp.141.3.448","article-title":"Open trial of S-adenosylmethionine for treatment of depression","volume":"141","author":"Lipinski","year":"1984","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0111|cit111","article-title":"A double-blind, placebo-controlled trial of intravenous ademetionine (SAMe) in the treatment of major depression (DSM III-R)","author":"Macher","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD011286.pub2-BIB0112|cit112","first-page":"207","article-title":"A double blind placebo controlled trial of intravenous ademetionine (SAMe) in the treatment of major depression","volume":"24","author":"Macher","year":"2000","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1158S","DOI":"10.1093\/ajcn\/76.5.1158S","article-title":"Role of S-adenosyl L-methionine in the treatment of depression: a review of the evidence","volume":"76","author":"Mischoulon","year":"2002","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0115|cit115","first-page":"1051","article-title":"Alternative therapies: Part I. Depression, diabetes, obesity","volume":"62(5)","author":"Morelli","year":"2000","journal-title":"American Family Physician"},{"issue":"9063","key":"10.1002\/14651858.CD011286.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","article-title":"Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0117|cit117","first-page":"17","article-title":"Prevalence and management of treatment-resistant depression","volume":"68 Suppl 8","author":"Nemeroff","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0118|cit118","unstructured":"National Institute for Health and Care Excellence Depression in adults. The treatment and management of depression in adults NICE clinical guideline 90 October 2009"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0014-2999(89)90205-7","article-title":"Acute effects of S-adenosylmethionine on catecholaminergic central function","volume":"163","author":"Otero-Losado","year":"1989","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0306-3623(89)90186-9","article-title":"Acute changes in 5HT metabolism after S-adenosylmethionine administration","volume":"20","author":"Otero-Losado","year":"1989","journal-title":"General Pharmacology"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0121|cit121","first-page":"1","article-title":"Recent experimental and clinical findings of the efficacy and safety of adementionine (SAMe) in the pharmacological treatment of depression","volume":"3","author":"Pancheri","year":"1997","journal-title":"Giornale Italiano di Psicopatologia"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s11920-003-0085-2","article-title":"S-adenosyl methionine in the treatment of depression: a comprehensive review of the literature","volume":"5","author":"Papakostas","year":"2003","journal-title":"Current Psychiatry Reports"},{"issue":"12","key":"10.1002\/14651858.CD011286.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1176\/appi.ajp.2010.10091252r","article-title":"'Discrepancy in response and remission rates for SAMe-treated patients in a double-blind, randomized clinical trial': reply to Fleisch et al [letter]","volume":"167","author":"Papakostas","year":"2010","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD011286.pub2-BIB0124|cit124","first-page":"3","article-title":"SAMe-dependent transmethylation in the depressive syndromes: evaluation of the therapeutic effect of S-adenosylmethionine using Hamilton Rating Scale","volume":"10","author":"Pinzello","year":"1972","journal-title":"Quaderno Terapeutico Sperimentale; Supplemento Biochimica e Biol Sperimentale"},{"issue":"12","key":"10.1002\/14651858.CD011286.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00005053-200012000-00002","article-title":"Short-term spontaneous improvement rates in depressed outpatients","volume":"188","author":"Posternak","year":"2000","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"4","key":"10.1002\/14651858.CD011286.pub2-BIB0126|cit126","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002235.pub2","article-title":"S-adenosyl-L-methionine for alcoholic liver diseases","author":"Rambaldi","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0127|cit127","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomised controlled trials: to whom do the results apply?","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0129|cit129","first-page":"164","article-title":"Down with odds ratios!","volume":"1","author":"Sackett","year":"1996","journal-title":"Evidence Based Medicine"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpsychires.2009.06.003","article-title":"Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines","volume":"44","author":"Sarris","year":"2010","journal-title":"Journal of Psychiatric Research"},{"issue":"4-5","key":"10.1002\/14651858.CD011286.pub2-BIB0131|cit131","first-page":"141","article-title":"Is S-adenosyl methionine (SAMe) for depression only effective in males? A re-analysis of data from a randomized controlled trial","volume":"48","author":"Sarris","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-244X-4-38","article-title":"S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV\/AIDS","volume":"4","author":"Shippy","year":"2004","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0895-4356(94)90191-0","article-title":"Clinically useful measures of effect in binary analyses of randomized trials","volume":"47","author":"Sinclair","year":"1994","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011286.pub2-BIB0134|cit134","first-page":"87","article-title":"Cost of depression in Europe","volume":"9","author":"Sobocki","year":"2006","journal-title":"Journal of Mental Health Policy and Economics"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3565(25)31670-8","article-title":"Intestinal absorption of S-adenosyl-L-methionine","volume":"209","author":"Stramentinoli","year":"1979","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1079\/NRR2006119","article-title":"One-carbon metabolism in psychiatric illness","volume":"19","author":"Sugden","year":"2006","journal-title":"Nutrition Research Reviews"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0137|cit137","volume-title":"Mental disorders: glossary and guide to their classification in accordance with the ninth revision of the International Classification of Diseases","author":"World Health Organization","year":"1978"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0138|cit138","volume-title":"International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10)","author":"World Health Organization","year":"1992"},{"key":"10.1002\/14651858.CD011286.pub2-BIB0139|cit139","first-page":"132","article-title":"S-adenosylmethionine (SAMe) as treatment for depression: a systematic review","volume":"28","author":"Williams","year":"2005","journal-title":"Clinical and Investigative Medicine"},{"issue":"9","key":"10.1002\/14651858.CD011286.pub2-BIB0140|cit140","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011286","article-title":"S-adenosyl methionine (SAM-e) for depression in adults","author":"Galizia","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011286.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T10:33:55Z","timestamp":1749638035000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011286.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,10]]},"references-count":140,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011286.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,10]]}}}